USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment Read more
Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 mL pharmacy bulk vial Read more
Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData Read more